Analysis assesses cognitive decline linked to pace of aging in a large cohort, suggesting implications for patient care.
Introduction The geroscience hypothesis proposes systemic biological aging is a root cause of cognitive decline. Methods We analyzed Framingham Heart Study Offspring Cohort data (n=2,296; 46% male; baseline age M =62, SD=9, range=25-101y). We measured cognitive decline across two decades of neuropsychological-testing follow-up. We measured pace of aging using the DunedinPACE epigenetic clock. Analysis tested if participants with faster DunedinPACE values experienced more rapid preclinical cognitive decline as compared to those with slower DunedinPACE values. Results Participants with faster DunedinPACE had poorer cognitive functioning at baseline and experienced more rapid cognitive decline over follow-up. Results were robust to confounders and consistent across population strata. Findings were similar for the PhenoAge and GrimAge epigenetic clocks. Discussion Faster pace of aging is a risk factor for preclinical cognitive decline. Metrics of biological aging may inform risk stratification in clinical trials and prognosis in patient care.
No takes yet. Share an insight, caveat, or question.
Savin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: